26 results were returned
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
We have advised Aphria Deutschland GmbH on its tender for the cultivation, processing and delivery of cannabis for medical purposes.
Bird & Bird has been acting for Earthport since 2009 and was appointed to take the company through its global expansion over the last 10 years.
Bird & Bird are pleased to announce the promotion of three partners, as well as eight Senior Counsel/Counsel/Legal Directors from across our global offices.
We are delighted to announce three promotions to Partner, three to Senior Counsel and 24 to Counsel from across our international team.
International law firm Bird & Bird advises Mitsubishi Chemical Advanced Materials (MCAM), a leading global manufacturer of high-performance materials and a business division of Mitsubishi Chemical Corporation, Japan, on ...